EFFECT OF COMPLEX HOMEOPATHIC DRUG CONTAINING COENZYME Q ON PARAMETERS OF OXIDATIVE STRESS AND HEMODYNAMICS IN EXPERIMANTAL DIABETES MELLITUS

Aim. To study the influence of complex homeopathic drug ubichinon compositum on hemodynamics, Na,K-ATPase activity, parameters of oxidative stress and serum nitric oxide (NO) metabolites concentration in experimental diabetes mellitus.

Materials and methods. Diabetes mellitus was induced by the administration of 5% alloxan solution to 75 rats, 15-18 mg/100 g of body weight; 20 rats without diabetes com￾prised control group. The parameters of macro- and microhemodynamic, lipid peroxidation, Na,K-ATPase activity, and stable NO metabolites concentration have been compared in animals with experimental diabetes mellitus under 1 month administration of ubichinon compositum (0,11 mg/100g of body weight).

Results. Experimental diabetes mellitus was shown to be associated with the development of oxidative stress expressed as activation of lipid peroxidation — increase of maloniс dialdehyde (MDA) concentration both in serum and cortex and medulla substances of renal tissues. At the same time, the antioxidant potential as well as the endothelial function (assesed as NO metabolites concentration) were decreased as compared with control animals. Administration of ubichinon compositum for 1 month resulted in restoration of stable NO metabolites concentration and Na,K-ATPase activity, as well as reduction of lipid peroxidation in blood and renal tissues

Conclusion. The administration of ubichinon compositum resulted in reduction of hemodynamic manifestations of microvascular complications of diabetes mellitus.

1. Davila-Esqueda M.E., Vertiz-Hernandez A.A., Martinez-Morales F. Comparative analysis of the renoprotective effects of pentoxifylline and vitamin E on streptozotocin-induced diabetes mellitus. Ren Fail 2005;27(1):115-22.

2. de Haan J.B., Stefanovic N., Nikolic-Paterson D. et al. Kidney expression of glutathione peroxidase-1 is not protective against streptozotocin-induced diabetic nephropathy. Am J Physiol Renal Physiol 2005;289(3):F544-51.

3. Дзугкоева Ф.С., Кастуева Н.Э., Каряева Э.А., Дзугкоев С.Г. Патогенетические аспекты диабетических ангиопатий и их антиокси- дантная коррекция (тезисы). Успехи современного естествознания 2006;(6):71-2.

4. Kojda G., Harrison D. Interactions between NO and reactive oxygen species: pathophysiological importance in atherosclerosis, hypertension, diabetes and heart failure. Cardiovasc Res 1999;43(3):562-71.

5. Ванин А.Ф. Оксид азота в биомедицинских исследованиях. Вестн Росс Акад Мед Наук. 2000;(4):3-5.

6. Rosca M.G., Mustata T.G., Kinter M.T. et al. Glycation of mitochondrial proteins from diabetic rat kidney is associated with excess superoxide formation. Am J Physiol Renal Physiol 2005;289(2):F420-30.

7. Laursen J.B., Rajagopalan S., Galis Z. et al. Role of superoxide in angiotensin II-induced but not catecholamine-induced hypertension. Circulation. 1997;95(3):588-93.

8. Волчегорский И.А., Рассохина Л.М., Мирошниченко И.Ю. Антиоксиданты при экспериментальном сахарном диабете. Проблемы эндокринологии 2008;54(5):43-50.

9. Yin X., Zhang Y., Yu J. et al. The antioxidative effects of astragalus saponin I protect against development of early diabetic nephropathy.J Pharmacol Sci 2006;101(2):166-73.

10. Капелько В.И.Активные формыкислорода, антиоксидантыи профилактика заболеваний сердца. РМЖ 2003;11(21):1185-8.

11. Asakawa T., Matsushita S. Coloring conditions of thiobarbituric acid test for detecting lipid hydroperoxides. Lipids 1980;15(3):137-40.

12. Королюк М.А., Иванова Л.И., Майорова И.Г., Токарев В.Е. Метод определения активности каталазы. Лаб дело 1988;(1):16-9.

13. Метельская В.А., ГумановаН.Г. Скрининг-метод определения уровня метаболитов оксида азота в сыворотке крови человека. Клин лаб диагн 2005;(6):15-8.

14. Scou J.C. The influence of some cations on an adenosine triphosphatase from peripheral nerve. Biochim Biophys Acta 1957;23(2):394-401.

15. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193(1):265– 75.

16. Петряйкина Е.Е., Мартынова М.И. Исследование состояния кожи при сахарном диабете 1 типа у детей неинвазивными методами (обзор литературы). Медицинский научный и учебно-методический журнал 2002;(11):64-119.

17. Winocour P.D. Platelets abnormality in diabetes mellitus. Diabetes 1992;41 Suppl 2:26-31.

18. Cohen M.P., Lautenslager G.T., Hud E. et al. Inhibiting albumin glycation attenuates dysregulation ofVEGFR-1 and collagen IVsubchain production and the development of renal insufleiciency. Am J Physiol Renal Physiol 2007;292(2):F789-95.

19. Flyvbjerg A. Inhibition and reversibility of renal changes: lessons from diabetic kidney disease. Acta Paediatr Suppl 2006;95(451):83-92.

20. Флеров М.А., Смирнова Н.Н., Светлова З.В. Перекисное окисление белков, плазмы крови больных сахарным диабетом типа 1. Проблемы эндокринологии 2003;49(4):3-8.